EOM PHARMACEUTICAL HLDNGS (IMUC) Stock Price, News & Analysis
Price Move History
- Daily moves over 5%
- 117 157 sessions, October 27, 2025 to October 27, 2026
- Largest daily move
- +174.6% close of January 2, 2026
- 1-year change
- -33.7% closing prices, October 27, 2025 to October 27, 2026
- 1-month change
- -53.7% closing prices, September 25, 2026 to October 27, 2026
Company Description
EOM PHARMACEUTICAL HLDNGS (OTC: IMUC) is classified in the biotechnology industry within the Healthcare sector and carries a market capitalization of $9.5M.
IMUC has declined 33.7% over the past year. The last closing price was $0.0750.
For FY2017, EOM PHARMACEUTICAL HLDNGS reported revenue of $0 with net income of -$14.3M and diluted earnings per share of -$1.23.
This page collects what Stock Titan holds for IMUC, including price data, latest news, financial highlights, and short interest trends.
Stock Performance
EOM PHARMACEUTICAL HLDNGS (IMUC) closed at $0.0750 on October 27, 2026. Over the past 12 months, the price has lost 33.7%.
IMUC Metrics & Rankings
Price returns through October 27, 2026. Month-to-date and YTD include the first trading day. Ranking links may use different dates.
Latest News
EOM PHARMACEUTICAL HLDNGS has 4 recent news articles. Of the recent coverage, 1 article coincided with positive price movement and 3 with negative movement. Key topics include clinical trial, covid-19, acquisition. View all IMUC news →
SEC Filings
Financial Highlights
operating income reached -$21.2M, and net income was -$14.3M. Diluted earnings per share stood at -$1.23. The company generated -$16.7M in operating cash flow. The current ratio was 2.97, measuring current assets divided by current liabilities.
Upcoming Events
Short Interest History
Short interest in EOM PHARMACEUTICAL HLDNGS (IMUC) currently stands at 40 shares, representing 0.0% of the float.
Days to Cover History
Days to cover for EOM PHARMACEUTICAL HLDNGS (IMUC) currently stands at 1.0 days. The ratio is the reported short interest divided by the average daily trading volume.
IMUC Company Profile & Sector Positioning
EOM PHARMACEUTICAL HLDNGS (IMUC) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the OTC.
Investors comparing IMUC often look at related companies in the same sector, including SIRONA BIOCHEM CORP (SRBCF), GENFLOW BIOSCIENCES PLC (GENFF), PREVECEUTICAL MED INC NEW (PRVCF), ZEO SCIENTIFIX INC (ZEOX), and MARVEL BIOSCIENCES CORP (MBCOF). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate IMUC's relative position within its industry.